ArticlePloS one2020

Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer.

Yixuan Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.